Throughout Europe, obesity remains one of the most pressing public health challenges of our time. More than one billion people worldwide are currently living with obesity.
Furthermore, projections indicate that, by 2030, nearly half of the global adult population could be overweight or obese.
The impact on individuals, healthcare systems and society is profound. Prevention and sustainable management strategies are therefore more important than ever.
At the same time, the rapid rise of GLP-1 therapies is reshaping weight loss expectations.
These medical advances are transforming the conversation, yet they do not replace the fundamental need for high-quality nutrition. Instead, they highlight the importance of comprehensive dietary support before, during and after weight-loss interventions.
For nutraceutical, food and beverage manufacturers across Europe, this shift represents a significant opportunity to innovate with purpose.
A shift from short-term results to lifecycle support
Weight management is no longer viewed as a simple matter of calorie reduction and exercise. Although early product concepts focused primarily on reducing energy intake, today’s landscape demands broader, lifecycle-based solutions.
Expert consensus increasingly frames GLP-1 therapy as a sequence of stages: metabolic preparation, active weight loss, maintenance and eventual discontinuation.
Each stage presents distinct nutritional needs. Before medication, supporting the body’s natural metabolic responses can be beneficial.
During weight loss, maintaining muscle mass, digestive comfort and adequate nutrient intake become critical. In the maintenance phase, appetite stabilisation and metabolic support are central.
Following discontinuation, preventing weight regain is a key concern. Importantly, many consumers continue to pursue weight management using natural dietary approaches, either instead of or alongside medication.
In all cases, nutrient-dense formulations remain essential.
Raising the benchmark for “effective” nutrition
The visibility of GLP-1 therapies has raised consumer expectations. With clinical trials demonstrating substantial weight loss, the definition of efficacy has evolved.
Products positioned for weight management must now offer more than reduced calories. They need to deliver measurable, physiologically relevant benefits.
Key areas of focus include
- satiety and appetite regulation
- blood sugar management and metabolic health
- digestive and gut health
- muscle preservation during weight loss
- sustained energy release.
Consumers are also increasingly aware that medication alone is not a complete solution. Without dietary adaptation, weight regain after discontinuation remains a significant risk.
This underscores the importance of science-backed functional ingredients that support long-term behavioural change.
A science-backed toolbox for comprehensive weight management
To meet these evolving demands, BENEO offers a broad portfolio of functional ingredients designed to holistically support weight management — whether before, during or after GLP-1 use or within natural approaches.
Proven prebiotic fibres
Orafti® Inulin and Oligofructose, derived from chicory root, are scientifically proven prebiotics that support digestive health and long-term weight control by increasing satiety, reducing calorie intake and improving body composition.
However, not all fibres deliver equal benefits.
Chicory root fibres belong to the limited group of prebiotics that comply with the International Scientific Association for Probiotics and Prebiotics definition and are supported by more than 25 years of scientific research.
Beyond their physiological benefits, they also enable sugar and fat reduction, making them highly versatile for reformulation in meal replacements, bars, dairy alternatives and functional snacks.
Beta-glucan-rich wholegrain barley
Orafti® β-Fit, a wholegrain barley flour rich in beta-glucans, supports fibre enrichment while contributing to blood sugar management and cardiovascular health.
Its dual relevance for metabolic and heart health makes it particularly attractive in European markets where health-conscious consumers seek multiple benefits.
Additionally, beta-glucans support appetite control and help consumers to feel full. Published study data show an effect on satiety with fullness sensations starting from just 3 g of beta-glucans per serving.
Low-glycaemic carbohydrates that support GLP-1 release
Palatinose™, a low-glycaemic carbohydrate derived from sugar beet, has been scientifically shown to stimulate the body’s own GLP-1 release and promote fat oxidation.
It delivers sustained energy and supports balanced blood sugar responses, even when consumed before a meal.
For nutraceutical developers, this offers opportunities in powders, ready-to-drink formats and targeted metabolic health concepts aligned with the growing interest in natural GLP-1 stimulation.
High-quality plant-based proteins
During weight loss, preserving lean muscle mass is essential. BENEO’s faba bean protein concentrate and rice protein can be combined to achieve a complete essential amino acid profile.
These ingredients are suitable for protein-enriched snacks, dairy alternatives and meal-replacement formulations designed to support muscle maintenance.
Innovation with regulatory confidence
In Europe’s highly regulated environment, scientific substantiation and compliant claims are non-negotiable. As the weight management category evolves, brands must ensure that positioning remains credible and transparent.
Combining application technology, scientific knowledge and legislative guidance, BENEO supports customers with its integrated chain of expertise.
From reformulation and fibre enrichment to metabolic health positioning, this collaborative approach helps manufacturers to translate nutritional science into market-ready concepts.
Turning momentum into meaningful progress
The scale of the obesity challenge demands collective action. Although GLP-1 therapies are reshaping the conversation, sustainable solutions will ultimately depend on accessible, nutrient-dense food and nutraceutical products that support long-term health.
For manufacturers, the opportunity lies in moving beyond single-claim positioning towards holistic concepts that address appetite regulation, metabolic balance, digestive health and muscle preservation in an integrated way.
Explore the next generation of weight management solutions
Whether you are developing meal replacements, functional beverages, bars or targeted nutraceutical formulations, BENEO’s science‑backed ingredients can help you to create differentiated, future-ready products for Europe’s weight-conscious consumers.
